콘텐츠로 건너뛰기
Merck

주요 문서

모든 문서 보기

858141C

Avanti

17:1 Lyso PS

Avanti Research™ - A Croda Brand

동의어(들):

110724

조직 및 계약 가격을 보려면 로그인를 클릭합니다.

크기 선택

보기 변경

제품정보 (DICE 배송 시 비용 별도)

실험식(Hill 표기법):
C23H43NNaO9P
CAS 번호:
1246298-15-6
Molecular Weight:
531.55
UNSPSC Code:
51191904
NACRES:
NA.25
기술 서비스
도움이 필요하신가요? 저희 숙련된 과학자 팀이 도와드리겠습니다.
도움 문의

제품 이름

17:1 Lyso PS, 1-(10Z-heptadecenoyl)-2-hydroxy-sn-glycero-3-[phospho-L-serine] (sodium salt), chloroform

assay

99% (LPS; may contain up to 15% of the 2-LPS isomer, TLC)

form

liquid

packaging

pkg of 1 × 1 mL (858141C-5mg), pkg of 1 × 4 mL (858141C-100mg)

manufacturer/tradename

Avanti Research™ - A Croda Brand 858141C

concentration

25 mg/mL (858141C-100mg), 5 mg/mL (858141C-5mg)

lipid type

phospholipids
cardiolipins

shipped in

dry ice

storage temp.

−20°C

SMILES string

O[C@](COP([O-])(OC[C@](C([O-])=O)([H])[NH3+])=O)([H])COC(CCCCCCCC/C=C\CCCCCC)=O.[Na+]

InChI

1S/C23H44NO9P.Na/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-22(26)31-17-20(25)18-32-34(29,30)33-19-21(24)23(27)28;/h7-8,20-21,25H,2-6,9-19,24H2,1H3,(H,27,28)(H,29,30);/q;+1/p-1/b8-7-;/t20-,21+;/m1./s1

InChI key

OALJMCAGNYARLY-XZEOLHCOSA-M

Application

17:1 Lyso PS may be used as a standard in graphitized carbon black-solid phase extraction (GCB-SPE) method for lipid extraction. It may also be used as an internal standard in the metabolomic analysis of cell and brain samples.

Biochem/physiol Actions

17:1 Lyso PS may serve as an odd-chained LIPIDOMIX™quantitative mass spectrometry internal standard.

Packaging

5 mL Clear Glass Sealed Ampule (858141C-100mg)
5 mL Clear Glass Sealed Ampule (858141C-5mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC
LIPIDOMIX is a trademark of Avanti Polar Lipids, LLC

Still not finding the right product?

Explore all of our products under

pictograms

Skull and crossbonesHealth hazard
GHS06,GHS08

signalword

Danger

Hazard Classifications

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

target_organs

Liver,Kidney, Respiratory system

저장 등급

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

wgk

WGK 3

flash_point_f

does not flash

flash_point_c

does not flash

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 문서 section.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Daisuke Ogasawara et al.
Nature chemical biology, 14(12), 1099-1108 (2018-11-14)
ABHD12 metabolizes bioactive lysophospholipids, including lysophosphatidylserine (lyso-PS). Deleterious mutations in human ABHD12 cause the neurological disease PHARC, and ABHD12-/- mice display PHARC-like phenotypes, including hearing loss, along with elevated brain lyso-PS and features of stimulated innate immune cell function. Here
Biyu Hou et al.
Life sciences, 245, 117352-117352 (2020-02-02)
The depot-specific differences in lipidome of visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) reflect heterogeneity of white adipose tissue (WAT), which plays a central role in its distinct response to outside stimuli. However, the detailed lipidome of depot-specific
Jordon M Inloes et al.
Biochemistry, 57(39), 5759-5767 (2018-09-18)
Deleterious mutations in the serine hydrolase DDHD domain containing 1 (DDHD1) cause the SPG28 subtype of the neurological disease hereditary spastic paraplegia (HSP), which is characterized by axonal neuropathy and gait impairments. DDHD1 has been shown to display PLA1-type phospholipase

국제 무역 품목 번호

SKUGTIN
858141C-5MG04061837793349
858141C-100MG04061837793332